Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: Correlation with histology and CD4-cell number

Leukemia and Lymphoma

Volumn 30, Issue 5-6, 1998, Pages 515-524

  Kersten, M J ^a   Van Gorp, J ^b,c   Pals, S T ^a   Boon, F ^a   Van Oers, M H J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Diaconessen Hospital   (Netherlands)

Author keywords

Adhesion molecules; AIDS; Epstein Barr virus; Non Hodgkin's lymphoma

Indexed keywords

CD4 ANTIGEN; CD44V ANTIGEN; CELL ADHESION MOLECULE; EPSTEIN BARR VIRUS ANTIGEN; HERMES ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BURKITT LYMPHOMA; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; EXON; GENE EXPRESSION; HUMAN; IMMUNE STATUS; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS LATENCY;

EID: 0031856312     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057564     Document Type: Article

References (52)

1. Zur Hausen, H., Schule-Holthausen, H., Klein, G., et al. (1970). EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the oropharynx. Nature, 228, 1056-1058.
2. Weiss, L. M., Movahed, L. A., Warnke, R. A. and Sklar, J. (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med, 320, 502-506.
3. van Gorp, J., de Bruin, P. C., Sie-Go, D. M. D. S., van Heerde, P., Ossenkoppele, G. J., Rademakers, L. H. P. M., Meijer, C. J. L. M. and van den Tweel, J. G. (1995). Nasal T cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathol, 27, 139-148.
4. Graig, F. E., Gulley, M. L. and Banks, P. M. (1993). Posttransplantation lymphoproliferative disorders. Am J Clin Pathol, 99, 265-276.
5. Cohen, J. I. (1991). Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine, 70, 137-160.
6. Levine, A. M. (1992). Acquired immunodeficiency syndrome-related lymphoma. Blood, 80, 8-20.
7. Anonymous. (1991). Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected \ patients surviving for prolonged periods on antiretroviral therapy - United States. MMWR, 40, 591-600.
8. Knowles, M. D., Chamulak, G. A., Subar, M., et al. (1988). Lymphoid neoplasia asociated with the acquired immunedeficiency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med, 108, 744-753.
9. Kaplan, L. D., Abrams, D. I., Feigal, E., et al. (1989). AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA, 261, 719-724.
10. MacMahon, E. M. E., Glass, J. D., Hayward, S. D., Mann, R. B., Becker, P. X., Charache, P., McArthur. J. C. and Ambinder, R. F. (1991). Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet, 338, 969-973.
11. Camilleri-Broet, S., Davi, F., Feuillard, J., Bourgeois, C., Seilhean, D., Hauw, J. J. and Raphael, M. (1995). High expression of Latent Membrane Protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in Acquired Immunodeficiency Syndrome-related primary brain lymphomas. Blood, 86, 432-435.
12. Hamilton-Dutoit, S. J., Raphael, M., Audoin, J., Diebold, J., Lisse, I., Pedersen, C., Oksenhendler, E., Marelle, L. and Pallesen, G. (1993). In situ demonstration of Epstein-Barr virus small RNA's (EBER 1) in Acquired Immunodeficiency Syndrome related lymphomas: correlation with tumor morphology and primary site. Blood, 82, 619-624.
13. Hamilton-Dutoit, S. J., Rea, D., Raphael, M., Sandvej, K., Delecluse, H. J., Gisselbrecht, C., Marelle, L., van Krieken, J. H. J. M. and Pallesen, G. (1993). Epstein-Barr virus-latent gene expression and tumor cell phenotype in Acquired Immunodeficiency Syndrome-related non-Hodgkin's lymphoma. Am J Pathol, 143, 1072-1085.
14. Carbone, A., Tirelli, U., Gloghini, A., Volpe, R. and Boiocchi, M. (1993). Human Immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol, 11, 1674-1681.
15. Pedersen, C., Gerstoft, J., Lundgren, J. D., Skinhoj, P., Bottzauw, J., Geisler, C., Hamilton-Dutoit, S. J., Thorsen, S., Lisse, I., Ralfkiaer, E. and Pallesen, G. (1991). HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer, 27, 1416-1423.
16. Birx, D. L., Redfield, R. R. and Tosato, G. (1986). Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDSrelated disorders. N Engl J Med, 314, 874-879.
17. Blumberg, R. S., Paradis, T., Byington, R., Henle, W., Hirsch, M. S. and Schooley, R. T. (1987). Effects of Human Immunodeficiency Virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Inf Dis, 155, 877-890.
18. Kersten, M. J., Klein, M. R., Holwerda, A. M., Miedema, F. and van Oers, M. H. J. (1997). EBV-specific cytotoxic T-cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J Clin Invest, 99, 1525-1533.
19. Lesley, J., Hyman, R. and Kincade, P.W. (1993). CD44 and its interaction with extracellular matrix. Adv Immunol, 54, 271-335.
20. Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U. and Bell, J. I. (1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA, 89, 12160-12164.
21. Horst, E., Meijer, C. J. L. M., Radaszkiewicz, R., Ossekoppele, G. J., van Krieken, J. H. J. M. and Pals, S. T. (1990). Adhesion molecules in the prognosis of diffuse largecell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/CD18), and ICAM-1 (CD54), Leukemia, 4, 595-599.
22. Koopman, G., Heider, K.H., Horst, K., Adolf, G. R., v.d. Berg, F., Ponta, H., Herrlich, P. and Pals, S. T. (1993). Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44., J Exp Med, 177, 897-904.
23. Stauder, R., Eisterer, W., Thaler, J. and Gunthert, U. (1995). CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood, 85, 2885-2899.
24. Mulder, J. W. R., Kruyt, P. M., Sewnath, M., Oosting, J., Seldenrijk, C. A., Weidema, W. F., Offerhaus, G. J. A. and Pals, S. T. (1994). Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet, 344, 1470-1472.
25. Kaufmann, M., Heider, K. H., Sinn, H. P., von Minekwitz, G., Ponta, H. and Herrlich, P. (1995). CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet, 345, 615-619.
26. Stansfeld, A. G., Diebold, J. and Kapanci, Y. (1988). Updated Kiel classification for lymphomas. Lancet, i. 292-293.
27. The non-Hodgkin's lymphoma classification project: National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. (1982) Cancer, 49, 2112-2135.
28. van Gorp, J., Weiping, L., Jacobse, K., Yong-Huei, L., Feng-Yuan, L., de Weger, R. A. and Li, G. (1994). Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J Pathol, 173, 81-87.
29. Pals, S. T., Hogervorst, F., Keizer, G. D., Thepen, T., Horst,. E. and Figdor, C. G. (1989). Identification of a widely distributed 9OkD glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol, 13, 851-857.
30. Heider, K. H., Hofmann, M., Horst, E., van den Berg, F., Ponta, H., Herrlich, P. and Pals, S. T. (1993). A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol, 120, 227-234.
31. Neri, A., Barriga, F., Inghirami, G., Knowles, D. M., Neequaye, J., Magrath, I. T. and Dalla-Favera, R. (1991). Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome associated lymphoma. Blood, 77, 1092-1098.
32. Shibata, D., Weiss, L. W., Hernandez, A. M., Nathwani, B. N., Bernstein, L. and Levine, A. M. (1993). Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the Human Immunodeficiency virus. Blood, 81, 2102-2109.
33. Billaud, M., Rousset, F., Calender, A., Cordier, M., Aubry, J. P., Laisse, V. and Lenoir, G. M. (1990). Low expression of lymphocyte function-associated antigen (LFA)- and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Blood, 75, 1827-1833.
34. Gregory, C. D., Murray, R. L. Edwards, C. F. and Rickinson, A. B. (1988). Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific cytotoxic T cell surveillance. J Exp Med, 167, 1811-1824.
35. Lombardi, L., Newcomb, E. W. and Dalla-Favera, R. (1987). Pathogenesis of Burkitt lymphomas: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts, Cell, 49, 161-167.
36. Paganin, C., Bianchi, G., Lombardi, L., Dalla-Favera, R., Mantovani, A. and Allavena, P. (1994). Role of leukocyte-function-associated antigen-1 and very late antigen-4 in the adhesion and transmigration of c-myc-transfected B-lymphoblastoid cell lines across vascular endothelium. Int J Clin Lab Res, 24, 29-12.
37. Baldini, L. G. and Cro, L. M. (1994). Structure and function of VLA integrins: differential expression in B cell leukemia/lymphoma. Leukemia and lymphoma, 12, 197-203.
38. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B. (1992). Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med, 176, 157-168.
39. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G. and Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen 1. Nature, 375, 685-688.
40. Ballerini, P., Gaidano, G., Gong, J. Z., Tassi, V., Saglio, G., Knowles, D. M. and Dalla-Favera, R. (1993). Multiple genetic lesions in acquired immunodeficiency syndrome-related nonHodgkin's lymphoma. Blood, 81, 166-176.
41. Haluska, F.G., Russo, G., Kant. J., Andreef, M. and Croce, C. M. (1989). Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt's lymphoma: implications for their puthogenesis. Proc Natl Acad Sci USA, 86, 8907-8916.
42. Whittle, H. C., Brown, J., Marsh, K., Greenwood, B. M., Seidelin, P., Tighe, H. and Wedderburn, L. (1984). T-cell control of Epstein-Barr virus-infected B-cells is lost during P. falciparum malaria. Nature, 312, 449-452.
43. Cen. H., Williams, P. A., McWilliams, H. P., Breinig, M. C., Ho, M. and McKnight, J. L. C. (1993). Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphomproliferative disorders. Blood, 81, 1393-1403.
44. Wang, F., Tsang, S. F., Kurilla, M. G., Cohen, J. I. and Kieff, E. (1990). Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP-1. J Virol, 64, 3407-3416.
45. Cordier, M., Calender, A. and Billaud, M. (1990). Stable transfection of Epstein-Barr virus nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B cell activation molecules CD21 and CD23. J Virol, 64, 1002-1013.
46. Henderson, S., Rowe, M. and Gregory, C. (1991). Induction of bc12 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell, 65, 1107-1115.
47. Wang, D., Liebowitz, D., Wang, F., Gregory, C., Rickinson, A., Larson, R., Springer, T. and Kieff, E. (1988). Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: delction of the amino terminus abolishes activity. J Virol, 62, 4173-4182.
48. Walter, J., Schirrmacher, V. and Mosier, D. (1995). Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination. Int J Cancer, 61, 363-369.
49. Pals, T., Meijer, C. J. L. M. and Radaszkiewicz, T. (1991). Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas. Leukemia, 5, 628-631.
50. Jalkanen, S., Bargatze, R. Z., de los Toyos, J. and Butcher. E. C. (1987). Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol, 105, 983-990.
51. Rothlein, R., Dustin, M. L., Marlin, S. D. and Springer, T. A. (1986). A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol, 137, 1270-1274.
52. Sanchez-Madrid, F., de Landazuri, M. O., Morago, G., Cehrian, M. and Bernaheu, C. (1986). VLA-4, a novel polypeptide associated with the VLA molecular complex: cellular distribution and biochemical characterization. Eur J Immunol, 16, 1343-1349.